Read Article(All)

The list of (1) News and Articles (for free)
and (2) "U.S. eHealth Journal" (in Japanese, Subscription required)
貴社ビジネスをサポートする情報発信を目指します。
① 日米のヘルスケア産業情報 (無料) → ② 「米国eHealthジャーナル」(要・購読契約)
1-10 of 592 articles

News and Articles (Free)

0
[Yakuji Nippo]Continuation of considering making online medical care permanent - to add these points to guidelines revision by the next fall.
The Ministry of Health, Labor and Welfare (MHLW) will continue to consider making online medical care permanent inc...
  • Target market
    Japan
  • Business category
    Pharmaceutical, Biopharmaceutical, Regerative medicine, Medical device, Digital health, Others
  • Business function
    Marketing >
  • Author
    "LSMIP Editorial Office" of "CM Plus Corporation"
  • Availability
    Membership
0
(ジャーナル)
Flow社のうつ病治療デバイス、パンデミックが売上に寄与
<脳刺激と行動療法の組合せによる在宅のうつ病治療>スウェーデンの医療機器スタートアップ、Flow社 (Flow Neuroscience AB) のうつ病治療ヘッドセット「Flow tDCS」の売上が、CO...
  • Target market
    USA
  • Business category
    Medical device, Digital health
  • Business function
    Marketing >
  • Author
    "LSMIP Editorial Office" of "CM Plus Singapore Pte. Ltd."
  • Availability
    Membership
0
第3回 企業の海外進出・展開のポイント(ASEANのコンサルティングの現場から)
第3回:FS実施上のポイント 生産拠点としての進出/販売拠点としての進出海外に拠点を作るにあたっては、多くの企業が入念に下調べを行い綿密な計画を作成して進出、というのが通常です。ただし、その項目や...
  • Target market
    USA, Other countries
  • Business category
    Pharmaceutical, Biopharmaceutical, Regerative medicine, Medical device, Digital health, Others
  • Business function
    Business consulting >
  • Author
    "Takuya MAKIMURA" of ""
  • Availability
    Membership
0
第2回 企業の海外進出・展開のポイント(ASEANのコンサルティングの現場から)
第2回:海外事業の成功について(現地化と差別化、また海外事業の成功とは?)海外展開に成功している企業の共通点前回のコラムでは、海外事業の成功要因として「先行者利益」についてお話させて頂きましたが、...
  • Target market
    USA, Other countries
  • Business category
    Pharmaceutical, Biopharmaceutical, Regerative medicine, Medical device, Digital health, Others
  • Business function
    Business consulting >
  • Author
    "Takuya MAKIMURA" of ""
  • Availability
    Membership
0
企業の海外進出・展開のポイント(ASEANのコンサルティングの現場から)
はじめに:本コラムでは、東南アジアにおいて日系企業の進出をコンサルタントとしてサポートさせて頂いている筆者が、様々なプロジェクトの経験から、また海外各地で活躍されている日本や現地のビジネスマン・経...
  • Target market
    USA, Other countries
  • Business category
    Pharmaceutical, Biopharmaceutical, Regerative medicine, Medical device, Digital health, Others
  • Business function
    Business consulting >
  • Author
    "Takuya MAKIMURA" of ""
  • Availability
    Membership
0
慢性呼吸器疾患用スマート吸入器の市場動向
<市場拡大の予測:技術開発競争から新たな局面へ>スマート吸入器と呼ばれる、喘息・COPDなど慢性呼吸器疾患の服薬管理デバイスはスタートアップ企業を中心に技術革新が進み、市場が形成されつつある。米国...
  • Target market
    USA
  • Business category
    Medical device, Digital health
  • Business function
    Marketing >
  • Author
    "LSMIP Editorial Office" of "CM Plus Singapore Pte. Ltd."
  • Availability
    Membership
0
[Yakuji Nippo]Ministers Agreed on Off-year Revision - Settled on Coverage of "Deviation Rate of More than 5%", Prices to be Reduced for 70% of All Products
Minister of Finance Taro Aso, Chief Cabinet Secretary Katsunobu Kato and Minister of Health, Labor and Welfare Nori...
  • Target market
    Japan
  • Business category
    Pharmaceutical, Biopharmaceutical, Regerative medicine, Medical device, Digital health, Others
  • Business function
    Marketing >
  • Author
    "LSMIP Editorial Office" of "CM Plus Corporation"
  • Availability
    Membership
0
[Yakuji Nippo]280 generic products listed in National Health Insurance (NHI) Price List - "Lyrica" as the first generic drug and other drugs from 22 companies joined the list.
The Ministry of Health, Labor and Welfare (MHLW) will list 280 generic products in the price list of NHI today. The ...
  • Target market
    Japan
  • Business category
    Pharmaceutical, Biopharmaceutical, Regerative medicine, Medical device, Digital health, Others
  • Business function
    Marketing >
  • Author
    "LSMIP Editorial Office" of "CM Plus Corporation"
  • Availability
    Membership
What information are you looking for in articles?
Let us help you to find out the articles for your business requirements!
Like many other companies, we use cookies and other technologies, some of which are essential to make our website work. By clicking Accept or continuing to use our site, you agree to use these cookies and other technologies. To learn more, check out our privacy policy.
Accept